Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurocognitive functioning and genetic variation in patients with primary brain tumours.

The Lancet. Oncology - 1 Mar 2016

Wefel Jeffrey S, Noll Kyle R, Scheurer Michael E

Abstract excerpt

Impairment of neurocognitive functioning is a common result of cerebral neoplasms and treatment, although there is substantial heterogeneity in the pattern and severity of neurocognitive dysfunction across individuals and tumour types. The effects of many clinical and patient characteristics on neurocognitive functioning have been documented, but little research has been devoted to understanding the effect of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Brain Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition Disorders

Share to Cross-Sectional Studies

Share to Neuropsychological Tests

Share to Risk Assessment

Share to Sex Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 26972863
DOI: 10.1016/S1470-2045(15)00380-0
PMCID: PMC5215729

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurocognitive functioning and genetic variation in patients with primary brain tumours.PMID 26972863Read ↗

Comment on: Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.Semantic proximity Read ↗

Genetic Modulation of Neurocognitive Function in Glioma Patients.Semantic proximity Read ↗

Genetic variants and cognitive functions in patients with brain tumorsSemantic proximity Read ↗

BDNF, COMT, and DRD2 polymorphisms and ability to return to work in adult patients with low- and high-grade gliomaSemantic proximity Read ↗

APOE polymorphisms and cognitive functions in patients with brain tumors.Semantic proximity Read ↗

Cognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy.Semantic proximity Read ↗

Neurocognitive phenotypes and genetic dissection of disorders of brain and behavior.Semantic proximity Read ↗

Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors.Semantic proximity Read ↗

Using neurocognitive phenotypes to inform interventions for adult survivors of childhood cancer.Semantic proximity Read ↗

Cognitive functioning in a cohort of high-grade glioma patients.Semantic proximity Read ↗

The APOE ε4 allele in relation to pre- and postsurgical cognitive functioning of patients with primary brain tumors.Semantic proximity Read ↗

Predicting Late Radiation-Associated Neurocognitive and Endocrine Toxicity in Patients with Brain TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.